- Home
- CHRS vs HMST Comparison
CHRS vs HMST Comparison
Compare CHRS & HMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- HMST
- Stock Information
- Founded
- CHRS 2010
- HMST 1921
- Country
- CHRS United States
- HMST United States
- Employees
- CHRS N/A
- HMST N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- HMST Major Banks
- Sector
- CHRS Health Care
- HMST Finance
- Exchange
- CHRS Nasdaq
- HMST Nasdaq
- Market Cap
- CHRS 84.2M
- HMST 246.0M
- IPO Year
- CHRS 2014
- HMST 2012
- Fundamental
- Price
- CHRS $0.90
- HMST $13.24
- Analyst Decision
- CHRS Buy
- HMST Hold
- Analyst Count
- CHRS 3
- HMST 3
- Target Price
- CHRS $4.68
- HMST $14.17
- AVG Volume (30 Days)
- CHRS 1.2M
- HMST 68.7K
- Earning Date
- CHRS 08-07-2025
- HMST 07-28-2025
- Dividend Yield
- CHRS N/A
- HMST N/A
- EPS Growth
- CHRS N/A
- HMST N/A
- EPS
- CHRS N/A
- HMST N/A
- Revenue
- CHRS $272,251,000.00
- HMST $78,454,000.00
- Revenue This Year
- CHRS N/A
- HMST $161.80
- Revenue Next Year
- CHRS $106.56
- HMST $8.90
- P/E Ratio
- CHRS N/A
- HMST N/A
- Revenue Growth
- CHRS 19.87
- HMST N/A
- 52 Week Low
- CHRS $0.66
- HMST $8.41
- 52 Week High
- CHRS $2.43
- HMST $16.10
- Technical
- Relative Strength Index (RSI)
- CHRS 59.04
- HMST 64.81
- Support Level
- CHRS $0.73
- HMST $13.14
- Resistance Level
- CHRS $0.82
- HMST $13.67
- Average True Range (ATR)
- CHRS 0.04
- HMST 0.34
- MACD
- CHRS 0.02
- HMST 0.07
- Stochastic Oscillator
- CHRS 88.02
- HMST 83.12
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.